The most frequent type of age-related dementia is Alzheimer's disease. To discover novel therapeutic agents for Alzheimer's disease, a series of substituted pyrimidine derivatives were synthesized and evaluated for anti-Alzheimer's activity. All the synthesized compounds were validated by HNMR, CNMR, and HRMS to assess the structural conformance of the newly synthesized compounds.
View Article and Find Full Text PDF